As Sykes Enterprises Incorporate (SYKE) Valuation Rose, River Road Asset Management Has Decreased Its Position by $2.35 Million; Peregrine Asset Advisers Continues to Hold Holding in Johnson&Johnson (JNJ)

November 14, 2017 - By Michael Collier

Peregrine Asset Advisers Inc increased its stake in Johnson&Johnson (JNJ) by 921.7% based on its latest 2017Q2 regulatory filing with the SEC. Peregrine Asset Advisers Inc bought 35,255 shares as the company’s stock rose 6.85% with the market. The institutional investor held 39,080 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $5.17 million, up from 3,825 at the end of the previous reported quarter. Peregrine Asset Advisers Inc who had been investing in Johnson&Johnson for a number of months, seems to be bullish on the $374.61 billion market cap company. The stock declined 0.23% or $0.32 reaching $139.44 on the news. About 472,153 shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since November 14, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

River Road Asset Management Llc decreased its stake in Sykes Enterprises Incorporate (SYKE) by 10.93% based on its latest 2017Q2 regulatory filing with the SEC. River Road Asset Management Llc sold 71,239 shares as the company’s stock rose 14.17% with the market. The institutional investor held 580,483 shares of the technology company at the end of 2017Q2, valued at $19.46M, down from 651,722 at the end of the previous reported quarter. River Road Asset Management Llc who had been investing in Sykes Enterprises Incorporate for a number of months, seems to be less bullish one the $1.23 billion market cap company. The stock rose 0.46% or $0.13 reaching $28.69. About 21,498 shares traded. Sykes Enterprises, Incorporated (NASDAQ:SYKE) has risen 14.01% since November 14, 2016 and is uptrending. It has underperformed by 2.69% the S&P500.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Reuters.com which released: “Johnson & Johnson wins reversal of $72 million verdict over talc cancer risks” on October 17, 2017, also Prnewswire.com with their article: “Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to …” published on November 13, 2017, Startribune.com published: “Exit by Johnson & Johnson bolsters Medtronic’s insulin pump dominance” on November 11, 2017. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Johnson & Johnson Pipeline Impresses” published on November 06, 2017 as well as Businesswire.com‘s news article titled: “Zymeworks Announces License Agreement with Johnson & Johnson Innovation to …” with publication date: November 13, 2017.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 13 have Buy rating, 5 Sell and 5 Hold. Therefore 57% are positive. Johnson & Johnson had 83 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, October 19 by UBS. The stock of Johnson & Johnson (NYSE:JNJ) earned “Neutral” rating by Goldman Sachs on Monday, March 14. The stock has “Buy” rating by Argus Research on Wednesday, April 20. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by RBC Capital Markets on Wednesday, October 18. The stock has “Hold” rating by Jefferies on Tuesday, August 15. Citigroup initiated the shares of JNJ in report on Monday, September 25 with “Hold” rating. Wells Fargo upgraded Johnson & Johnson (NYSE:JNJ) rating on Monday, October 9. Wells Fargo has “Buy” rating and $149.0 target. The stock of Johnson & Johnson (NYSE:JNJ) earned “Hold” rating by Stifel Nicolaus on Wednesday, October 18. The firm earned “Outperform” rating on Tuesday, August 25 by Cowen & Co. The firm earned “Market Perform” rating on Thursday, January 26 by Wells Fargo.

Investors sentiment decreased to 0.83 in Q2 2017. Its down 0.03, from 0.86 in 2017Q1. It turned negative, as 50 investors sold JNJ shares while 878 reduced holdings. 105 funds opened positions while 667 raised stakes. 1.73 billion shares or 0.03% less from 1.73 billion shares in 2017Q1 were reported. Amp has 0.91% invested in Johnson & Johnson (NYSE:JNJ). Winch Advisory Ser Ltd Company reported 4,379 shares. Sather Fincl Gru Inc owns 10,695 shares. Howland Capital Management Limited Co accumulated 2.34% or 209,395 shares. Barrett Asset Management Ltd Liability reported 2.82% stake. Guinness Atkinson Asset accumulated 0.16% or 1,890 shares. Carl Domino, Florida-based fund reported 2,185 shares. The Minnesota-based Advantus Cap Management has invested 0.95% in Johnson & Johnson (NYSE:JNJ). Americafirst Capital Mgmt Ltd Liability Corporation owns 3,522 shares or 0.59% of their US portfolio. Trust Department Mb Savings Bank N A invested in 129,927 shares. Virginia Retirement System Et Al has invested 1.79% in Johnson & Johnson (NYSE:JNJ). Inspirion Wealth Advisors Limited Liability Company has invested 0.15% in Johnson & Johnson (NYSE:JNJ). Farmers Merchants Incorporated reported 145,340 shares or 1.6% of all its holdings. Choate reported 0% of its portfolio in Johnson & Johnson (NYSE:JNJ). Moreover, Eagle Asset Management Incorporated has 0.68% invested in Johnson & Johnson (NYSE:JNJ) for 850,365 shares.

More important recent Sykes Enterprises, Incorporated (NASDAQ:SYKE) news were published by: Globenewswire.com which released: “Sykes Enterprises, Incorporated Issues Notice of Release of First-Quarter 2017 …” on May 08, 2017, also Globenewswire.com published article titled: “Sykes Enterprises, Incorporated to Participate in Barrington Research’s Fall …”, Globenewswire.com published: “Sykes Enterprises, Incorporated to Participate in Wells Fargo’s 2017 Media …” on November 07, 2017. More interesting news about Sykes Enterprises, Incorporated (NASDAQ:SYKE) was released by: Globenewswire.com and their article: “Sykes Enterprises, Incorporated Completes Acquisition of Certain Assets of a …” with publication date: June 01, 2017.

River Road Asset Management Llc, which manages about $10.26 billion and $5.17 billion US Long portfolio, upped its stake in Sabra Health Care Reit Inc. (NASDAQ:SBRA) by 536,583 shares to 2.31 million shares, valued at $55.79M in 2017Q2, according to the filing. It also increased its holding in Qep Resources Inc. (NYSE:QEP) by 79,360 shares in the quarter, for a total of 823,640 shares, and has risen its stake in General Motors Company (NYSE:GM).

Among 5 analysts covering Sykes Enterprises (NASDAQ:SYKE), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Sykes Enterprises had 9 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Buy” rating by SunTrust given on Monday, October 9. Craig Hallum upgraded the shares of SYKE in report on Tuesday, March 8 to “Buy” rating. The firm has “Buy” rating given on Tuesday, January 17 by Sidoti. The rating was downgraded by Zacks on Wednesday, August 5 to “Strong-Buy”. The firm earned “Hold” rating on Friday, September 15 by Robert W. Baird. The rating was maintained by Robert W. Baird on Tuesday, August 8 with “Neutral”. The stock of Sykes Enterprises, Incorporated (NASDAQ:SYKE) has “Mkt Perform” rating given on Wednesday, January 20 by Barrington Research. The firm earned “Hold” rating on Friday, October 20 by Robert W. Baird.

Since May 15, 2017, it had 0 insider buys, and 2 selling transactions for $207,299 activity. Shares for $82,500 were sold by HOLDER JAMES T. WHITING PAUL L had sold 14,164 shares worth $463,871.

Analysts await Sykes Enterprises, Incorporated (NASDAQ:SYKE) to report earnings on February, 26. They expect $0.40 earnings per share, down 23.08% or $0.12 from last year’s $0.52 per share. SYKE’s profit will be $17.15M for 17.93 P/E if the $0.40 EPS becomes a reality. After $0.62 actual earnings per share reported by Sykes Enterprises, Incorporated for the previous quarter, Wall Street now forecasts -35.48% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: